Baron Silver Stevens Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Hold
444
0.03% 135
2026
Q1
$219K Sell
444
-25
-5% -$13.6K 0.03% 126
2025
Q4
$272K Sell
469
-18
-4% -$10.2K 0.04% 109
2025
Q3
$237K Sell
487
-116
-19% -$54K 0.03% 130
2025
Q2
$244K Buy
603
+108
+22% +$45.2K 0.04% 119
2025
Q1
$246K Hold
495
0.04% 104
2024
Q4
$257K Sell
495
-10
-2% -$5.5K 0.04% 102
2024
Q3
$312K Hold
505
0.05% 92
2024
Q2
$279K Sell
505
-1
-0.2% -$573 0.05% 92
2024
Q1
$294K Buy
506
+36
+8% +$20.2K 0.06% 96
2023
Q4
$249K Buy
+470
New +$227K 0.05% 97
2021
Q1
Sell
-121
Closed -$56K 423
2020
Q4
$56K Buy
+121
New +$56.7K 0.02% 133

Other funds holding TMO

Baron Silver Stevens Financial Advisors's TMO Position: Q2 2026 in Review

Baron Silver Stevens Financial Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 444 shares worth $223K. The position accounts for 0.03% of the portfolio, ranked #135.

Baron Silver Stevens Financial Advisors first reported a position in TMO in Q4 2020 and has held it in 12 quarters since. The position peaked at $312K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Baron Silver Stevens Financial Advisors held 444 shares of Thermo Fisher Scientific worth $223K as of Q2 2026.
  • Baron Silver Stevens Financial Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.03% of Baron Silver Stevens Financial Advisors's portfolio in Q2 2026, its #135 holding.
  • Baron Silver Stevens Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 12 quarters since.
  • Baron Silver Stevens Financial Advisors's Thermo Fisher Scientific position peaked at $312K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.